Business & Financial

Sales dip for IFF in Q2

Sales dip for IFF in Q2

Number one flavour and fragrance house reports a drop in sales for
the second quarter, hit by a slip in European and North American
sales. International Flavors & Fragrances had expected sales to
increase by 5 per cent on 2002,...

Sales slip for L'Oreal

Sales slip for L'Oreal

French beauty giant L'Oréal sees a drop in consolidated sales for
the first half of 2003 to €7.14bn, reflecting a drop of 3.2 per
cent. But company remains confident that on target for annual
objectives.

P&G gets green light from US

P&G gets green light from US

Procter & Gamble Germany has had the green light from US
regulatory body to proceed with its acquisition of Wella. The
company will continue to pursue the necessary regulatory and
governmental approvals in other major markets...

Henkel sells Wella stake

Henkel sells Wella stake

German beauty care company Henkel has accepted a takeover offer
from US consumer goods giant Procter & Gamble for its 6.86 per
cent stake in German haircare company Wella, the company said on
Friday. P&G has been in control...

Makeup cocktails from IMX

Makeup cocktails from IMX

US company IMX Cosmetics has launched a custom cosmetics line that
allows customers to mix their own personalised recipes for lip
gloss and other cosmetics and retrieve them at in-store computer
kiosks.

Avon continues mark creation

Avon continues mark creation

Avon Products, a direct seller of beauty and related products, has
announced it is to retain Creative Artists Agency (CAA) to provide
entertainment-based marketing strategies for the launch of its new
beauty business 'mark'.

Givenchy wins Fifi awards

Givenchy wins Fifi awards

Givenchy's Marc Jacobs Men took the awards for Men's Fragrance
Introduction of the Year Noveau Niche: Fragrance Sold in Specialty
Stores, Private Label under 500 doors and Men's Packaging of the
Year at the 2003 annual...

Fatty acid cream for mobility

Fatty acid cream for mobility

A cream composed of cetylated fatty acids (CFA) can improve quality
of life and mobility in patients with osteoarthritis, claims a
study conducted in the US by Connecticut university together with
bioceutical company Imagenetix.